TNFRSF17 and plasma cell myeloma: In addition to the three classic binding patterns (Fig. 6e–g), CD38 binding might assist the anti-BCMA scFv in connection with BCMA on myeloma cells (Fig. 6h), and BCMA coalescence could reversely strengthen CD38 binding (Fig. 6i) in view of their extracellular domains.